Neurostimulation for the Management of Epilepsy: Advances in Targeted Therapy.

IF 3 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Shristy Verma, Rishabha Malviya, Sathvik Belagodu Sridhar, Sonali Sundram, Javedh Shareef
{"title":"Neurostimulation for the Management of Epilepsy: Advances in Targeted Therapy.","authors":"Shristy Verma, Rishabha Malviya, Sathvik Belagodu Sridhar, Sonali Sundram, Javedh Shareef","doi":"10.2174/0113894501364865250525091633","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Epilepsy is a multifaceted neurological disorder marked by seizures that can present with a wide range of symptoms. Despite the prevalent use of anti-epileptic drugs, drug resistance and adverse effects present considerable obstacles. Despite advancements in anti-epileptic drugs (AEDs), approximately 20-30% of patients remain drug-resistant, highlighting the need for innovative therapeutic strategies.</p><p><strong>Aim: </strong>This study aimed to explore advancements in epilepsy diagnosis and treatment utilizing modern technology and medicines.</p><p><strong>Methods: </strong>The literature survey was carried out using Scopus, ScienceDirect, and Google Scholar. Data from the last 10 years were preferred to include in the study.</p><p><strong>Result: </strong>Emerging technologies, such as artificial intelligence, gene therapy, and wearable gadgets, have transformed epilepsy care. EEG and MRI play essential roles in diagnosis, while AI aids in evaluating big datasets for more accurate seizure identification. Machine learning and artificial intelligence are increasingly integrated into diagnostic processes to enhance seizure detection and classification. Wearable technology improves patient self-monitoring and helps clinical research. Furthermore, gene treatments offer promise by treating the fundamental causes of seizure activity, while stem cell therapies give neuroprotective and regenerative advantages. Dietary interventions, including ketogenic diets, are being examined for their ability to modify neurochemical pathways implicated in epilepsy.</p><p><strong>Conclusion: </strong>Recent technological and therapeutic developments provide major benefits in epilepsy assessment and treatment, with AI and wearable devices enhancing seizure detection and patient monitoring. Nonetheless, additional study is essential to ensure greater clinical application and efficacy. Future perspectives include the potential of optogenetics and advanced signal processing techniques to revolutionize treatment paradigms, emphasizing the importance of personalized medicine in epilepsy care. Overall, a comprehensive understanding of the multifaceted nature of epilepsy is essential for developing effective interventions and improving patient outcomes.</p>","PeriodicalId":10805,"journal":{"name":"Current drug targets","volume":" ","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113894501364865250525091633","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Epilepsy is a multifaceted neurological disorder marked by seizures that can present with a wide range of symptoms. Despite the prevalent use of anti-epileptic drugs, drug resistance and adverse effects present considerable obstacles. Despite advancements in anti-epileptic drugs (AEDs), approximately 20-30% of patients remain drug-resistant, highlighting the need for innovative therapeutic strategies.

Aim: This study aimed to explore advancements in epilepsy diagnosis and treatment utilizing modern technology and medicines.

Methods: The literature survey was carried out using Scopus, ScienceDirect, and Google Scholar. Data from the last 10 years were preferred to include in the study.

Result: Emerging technologies, such as artificial intelligence, gene therapy, and wearable gadgets, have transformed epilepsy care. EEG and MRI play essential roles in diagnosis, while AI aids in evaluating big datasets for more accurate seizure identification. Machine learning and artificial intelligence are increasingly integrated into diagnostic processes to enhance seizure detection and classification. Wearable technology improves patient self-monitoring and helps clinical research. Furthermore, gene treatments offer promise by treating the fundamental causes of seizure activity, while stem cell therapies give neuroprotective and regenerative advantages. Dietary interventions, including ketogenic diets, are being examined for their ability to modify neurochemical pathways implicated in epilepsy.

Conclusion: Recent technological and therapeutic developments provide major benefits in epilepsy assessment and treatment, with AI and wearable devices enhancing seizure detection and patient monitoring. Nonetheless, additional study is essential to ensure greater clinical application and efficacy. Future perspectives include the potential of optogenetics and advanced signal processing techniques to revolutionize treatment paradigms, emphasizing the importance of personalized medicine in epilepsy care. Overall, a comprehensive understanding of the multifaceted nature of epilepsy is essential for developing effective interventions and improving patient outcomes.

神经刺激治疗癫痫:靶向治疗的进展。
背景:癫痫是一种多方面的神经系统疾病,以癫痫发作为特征,可呈现多种症状。尽管普遍使用抗癫痫药物,但耐药性和不良反应存在相当大的障碍。尽管抗癫痫药物(aed)取得了进展,但约20-30%的患者仍然具有耐药性,这突出表明需要创新的治疗策略。目的:探讨现代技术和药物在癫痫诊断和治疗中的应用进展。方法:采用Scopus、ScienceDirect、谷歌Scholar进行文献调查。最近10年的数据更倾向于纳入研究。结果:新兴技术,如人工智能、基因治疗和可穿戴设备,已经改变了癫痫治疗。脑电图和MRI在诊断中发挥着至关重要的作用,而人工智能有助于评估大数据集,以更准确地识别癫痫发作。机器学习和人工智能越来越多地集成到诊断过程中,以增强癫痫的检测和分类。可穿戴技术改善了患者的自我监测,有助于临床研究。此外,基因治疗有望治疗癫痫发作的根本原因,而干细胞治疗具有神经保护和再生的优势。正在研究饮食干预,包括生酮饮食,是否能够改变与癫痫有关的神经化学通路。结论:最近的技术和治疗发展为癫痫评估和治疗提供了重大益处,人工智能和可穿戴设备增强了癫痫发作检测和患者监测。然而,进一步的研究是必要的,以确保更大的临床应用和疗效。未来的前景包括光遗传学和先进的信号处理技术的潜力,以彻底改变治疗范式,强调个性化医疗在癫痫治疗中的重要性。总的来说,全面了解癫痫的多面性对于制定有效的干预措施和改善患者预后至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current drug targets
Current drug targets 医学-药学
CiteScore
6.20
自引率
0.00%
发文量
127
审稿时长
3-8 weeks
期刊介绍: Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信